Ƶ

Visual Guide to AVERT's VTE Prevention in Cancer

— Apixaban effective against important chemotherapy side effect

Ƶ MedicalToday

Apixaban therapy resulted in lower rates of VTE and a higher rate of major bleeding compared with placebo among intermediate- to high-risk ambulatory patients with cancer who were starting chemotherapy.

image

Credit: Visualmed.org

Click on the graphic to read the full story.